GI
XENE icon

GAMMA Investing’s Xenon Pharmaceuticals XENE Stock Holding History

GAMMA Investing’s Portfolio XENE Stock Details XENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$30.9K Buy
830
+312
+60% +$18.5K ﹤0.01% 2672
2026
Q2 		$31.3K Buy
518
+145
+39% +$8.05K ﹤0.01% 2591
2026
Q1 		$21.7K Buy
373
+109
+41% +$5.02K ﹤0.01% 2672
2025
Q4 		$11.8K Buy
264
+79
+43% +$3.32K ﹤0.01% 2899
2025
Q3 		$7.43K Buy
185
+171
+1,221% +$6.02K ﹤0.01% 3014
2025
Q2 		$438 Buy
14
+6
+75% +$196 ﹤0.01% 3650
2025
Q1 		$268 Sell
8
-43
-84% -$1.63K ﹤0.01% 3741
2024
Q4 		$2K Sell
51
-8
-14% -$331 ﹤0.01% 3223
2024
Q3 		$2.32K Buy
59
+21
+55% +$847 ﹤0.01% 3024
2024
Q2 		$1.48K Buy
38
+3
+9% +$120 ﹤0.01% 2965
2024
Q1 		$1.51K Buy
35
+13
+59% +$598 ﹤0.01% 2839
2023
Q4 		$995 Buy
+22
New +$777 ﹤0.01% 2790

Other funds holding XENE

WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's XENE Position: Q3 2026 in Review

GAMMA Investing increased its Xenon Pharmaceuticals (XENE) stake by 60% in Q3 2026, buying an estimated $18.5K and bringing the position to 830 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2672.

GAMMA Investing first reported a position in XENE in Q4 2023 and has held it in 12 quarters since. The position peaked at $31.3K in Q2 2026. 5 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • GAMMA Investing held 830 shares of Xenon Pharmaceuticals worth $30.9K as of Q3 2026.
  • GAMMA Investing bought 312 Xenon Pharmaceuticals shares in Q3 2026, an estimated $18.5K.
  • Xenon Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2672 holding.
  • GAMMA Investing first reported a position in Xenon Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Xenon Pharmaceuticals position peaked at $31.3K in Q2 2026.
  • 5 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.